Search
Ekso Bionics Ord Shs
CHRNAdd to Watchlist
21.690USD
+1.270+6.22%
Close 09-18 16:00（ET）
3.13BMarket Cap
LossP/E TTM
Ekso Bionics Ord Shs (CHRN) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts
--
0 Strong Buy
1 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
20.750USD+3.08%
CHRN Analyst Recommendation Trends
In the current month, CHRN has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. CHRN average Analyst price target in the last month is 20.750.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
2
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
CHRN Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Boston Scientific Corp
BSX
11
17
6
0
0
34
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Thermo Fisher Scientific Inc
TMO
10
16
6
0
0
32
Edwards Lifesciences Corp
EW
10
14
8
0
0
32
Veeva Systems Inc
VEEV
7
15
8
1
0
31
Danaher Corp
DHR
11
13
4
0
0
28
Waters Corp
WAT
8
10
9
0
0
27
Agilent Technologies Inc
A
6
11
7
0
0
24
Illumina Inc
ILMN
5
7
7
2
1
22
Resmed Inc
RMD
2
7
10
1
1
21
Financial Forecasting
Based on analysts' estimates, CHRN EPS is projected to reach -0.060 in FY2026Q2, following reported EPS of -2.038 in FY2026Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
--
--
-0.06
-0.02
0.01
Actual
-0.36
-2.04
--
--
--
Surprise
--
--
--
--
--
FAQs
What is Ekso Bionics Ord Shs's expected revenue for the next quarter?
Ekso Bionics Ord Shs's expected revenue is 2.50M.
What is Ekso Bionics Ord Shs's price target?
Analysts forecast that Ekso Bionics Ord Shs's price target is USD 20.75, with the highest forecast at USD 32.00 and the lowest forecast at USD 9.50.
How have Ekso Bionics Ord ShsCHRN's recent earnings per share performed?
The market expectation was USD -2.04, while Ekso Bionics Ord ShsCHRN's earnings per share (EPS) for the previous quarter was USD -0.36. EPS for the next quarter is expected at USD 0.01.